Need Help? Call 1­-866-­796-­7386
« back to stock screener

  LGND stock: Ligand Pharmaceuticals Inc.

Current Rating
Strong Sell

Previous Rating

Strong Sell
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$189.25
Market Cap
3.28B
Sector
Health Care
Div. Growth
-
P/E
310.5
P/B
8.31
P/S
23.56
Dividend %
-
P/CF
-
P/FCF
38.0
Op. Cash Flow
93.6K
FCF
4.1
Op. Margin
48.30%
Net Margin
8.90%
ROE
3.20%
ROI
3.60%
ROA
1.90%
EPS Growth
884.60%
Current Ratio
1.0
Debt/Equity
4.70%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
BioLife Solutions Inc (BLFS) $9.51 - - 102M Strong Buy
Nephros, Inc. (NEPH) $0.62 - - 31.8M Strong Buy
DENTSPLY SIRONA Inc (XRAY) $46.57 - 0.70% 11.18B Strong Buy
Depomed Inc (DEPO) $6.34 - - 423.6M Strong Buy
Digirad Corporation (DRAD) $1.65 - 15.70% 29.2M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More